Discovery of TAK-137 and TAK-653, clinical candidates of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiators with reduced agonistic activities

被引：0

作者：

Nakamura, Shinji ^{[1
]}

Toyofuku, Masashi ^{[1
]}

Honda, Eiji ^{[1
]}

Imaeda, Toshihiro ^{[1
]}

Yokota, Akihiro ^{[1
]}

Sogabe, Satoshi ^{[1
]}

Kunugi, Akiyoshi ^{[1
]}

Kuno, Haruhiko ^{[1
]}

Kosugi, Yohei ^{[1
]}

Kori, Masakuni ^{[1
]}

Miki, Takashi ^{[1
]}

Kimura, Haruhide ^{[1
]}

Kuroita, Takanobu ^{[1
]}

Kaku, Tomohiro ^{[1
]}

机构：

[1] Takeda Pharmaceut Co Ltd, Fujisawa, Kanagawa, Japan

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 256卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

314

引用

页数：1

共 50 条

[21] The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering
Lin, SHS
Arai, AC
Wang, ZW
Nothacker, HP
Civelli, O
MOLECULAR PHARMACOLOGY, 2001, 60 (05) : 916 - 923
[22] Regulation of growth hormone secretion by α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in infantile, prepubertal, and adult male fats
González, LC
Pinilla, L
Tena-Sempere, M
Aguilar, E
ENDOCRINOLOGY, 1999, 140 (03) : 1279 - 1284
[23] Long-term alterations in benzodiazepine, muscarinic and α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor density following continuous cocaine administration
Keys, AS
Ellison, GD
PHARMACOLOGY & TOXICOLOGY, 1999, 85 (03): : 144 - 150
[24] Soluble Oligomers of Amyloid-β Peptide Disrupt Membrane Trafficking of α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Contributing to Early Synapse Dysfunction
Minano-Molina, Alfredo J.
Espana, Judit
Martin, Elsa
Barneda-Zahonero, Bruna
Fado, Rut
Sole, Montse
Trullas, Ramon
Saura, Carlos A.
Rodriguez-Alvarez, Jose
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (31) : 27311 - 27321
[25] Neuroprotective efficacy of YM872, an α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats
Takahashi, M
Ni, JW
Kawasaki-Yatsugi, S
Toya, T
Ichiki, C
Yatsugi, SI
Koshiya, K
Shimizu-Sasamata, M
Yamaguchi, T
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 287 (02): : 559 - 566
[26] α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype glutamate receptor (AMPAR) endocytosis is essential for N-methyl-D-aspartate-induced neuronal apoptosis
Wang, YS
Ju, W
Liu, LD
Fam, S
D'Souza, S
Taghibiglou, C
Salter, M
Wang, YT
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 41267 - 41270
[27] LY503430, a novel α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease
Murray, TK
Whalley, K
Robinson, CS
Ward, MA
Hicks, CA
Lodge, D
Vandergriff, JL
Baumbarger, P
Siuda, E
Gates, M
Ogden, AM
Skolnick, P
Zimmerman, DM
Nisenbaum, ES
Bleakman, D
O'Neill, MJ
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (02): : 752 - 762
[28] (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and kainate receptor subunit expression in mouse versus rat spinal cord white matter:: similarities in astrocytes but differences in oligodendrocytes
Brand-Schieber, E
Werner, P
NEUROSCIENCE LETTERS, 2003, 345 (02) : 126 - 130
[29] EFFECT OF NBQX, A NON-COMPETITIVE α-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID RECEPTOR ANTAGONIST, ON THE SNEEZE-INDUCED, ACTIVE URETHRAL CONTINENCE REFLEX IN RATS
Kawamorita, Naoki
Kaiho, Yasuhiro
Matsushita, Mabumi
Yamashita, Shinichi
Izumi, Hideaki
Miyazato, Minoru
Nakagawa, Haruo
Arai, Yoichi
JOURNAL OF UROLOGY, 2010, 183 (04): : E615 - E616
[30] Quinazolone-alkyl-carboxylic acid derivatives inhibit transmembrane Ca2+ ion flux to (+)-(S)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
Szárics, É
Nyikos, L
Barabás, P
Kovács, I
Skuban, N
Temesváriné-Major, E
Egyed, O
Nagy, PI
Kökösi, J
Takács-Novák, K
Kardos, J
MOLECULAR PHARMACOLOGY, 2001, 59 (04) : 920 - 928

← 1 2 3 4 5 →